EGFR and non-small cell lung carcinoma: Transfection of NSCLC cells with miR-146a mimic resulted in decreased EGFR protein levels and downstream signaling (ERK, AKT, and stat pathways) and these effects were reversed by miR-146a inhibitor treatment.